3.41 USD
↘ 0.10 (2.85%)AT CLOSE (11:59 AM EDT)
Sana Biotechnology, Inc. Common Stock
SANANASDAQ • USD
3.37
↘ 0.04 (1.29%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
3.37
↘ 0.04 (1.29%)
Market: CLOSED
Shares of Sana Biotechnology, Inc. Common Stock (SANA) are trading at $3.41. SANA shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, SANA trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 6, 2026.
Open?$3.51
High?$3.62
Low?$3.37
Prev. Close?$3.51
Volume?1.8M
Avg. Volume?3.0M
VWAP?$3.47
Rel. Volume?0.61x
Bid / Ask
Bid?$3.31 × 1.0K
Ask?$3.45 × 200
Spread?$0.14
Midpoint?$3.38
Valuation & Ratios
Market Cap?976.8M
Shares Out?278.3M
Float?158.0M
Float %?58.5%
P/E Ratio?N/A
P/B Ratio?8.19
EPS?-$0.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Themes
Employees
142
Market Cap
976.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-04
Address
188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
Phone: (206) 701-7914
SEATTLE, WA
Phone: (206) 701-7914
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.91Distress
Confidence?56%Low
Short InterestSqueeze Risk
Short % of Float?25.16%Squeeze Risk
Short Interest?39.7M
Days to Cover?13.2
Free Float158.0M
Avg Daily Volume3.0M
Settlement Date2026-07-15
Financial Health
Current Ratio?1.29Adequate
Quick Ratio?1.29Adequate
Cash Ratio?0.97Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?8.19HIGH▾
Peers100
S&P23
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-202.9%WEAK▾
S&P3
ROA?-64.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-133640000
Enterprise Value?$893.0M
Fundamentals ratios updated end of day